The high rate of type 1 diabetes in Finland remains unexplained. The country has one of the world’s highest recorded incidences, particularly among children, but researchers have yet to establish why the condition is so common.
According to Finnish clinical guidelines, 45,170 people were living with type 1 diabetes in the country in 2024. The autoimmune disease develops when the immune system attacks insulin-producing cells in the pancreas, leaving patients dependent on insulin treatment.
Environmental clues in Finland and neighbouring Russia
Lena Thorn, a diabetes specialist and associate professor at the University of Helsinki, told Finnish public broadcaster Yle that comparisons with neighbouring Russia offer an important clue. Despite similarities in genetic background across the border, the disease is considerably more common on the Finnish side, she said.
Thorn also pointed to the rising risk among people who move to Finland. Such patterns suggest that environmental conditions may play a role alongside inherited susceptibility, although they do not identify a specific exposure.
Limited winter daylight and vitamin D deficiency are among the explanations proposed for the high rates observed across Nordic countries. Thorn stressed that there is no clear evidence that either factor explains Finland’s situation.
Finnish diabetes studies point to environmental influences
A nationwide register-based study of 16,307 children diagnosed between 1990 and 2019 found that cases clustered in place and time. The researchers said this pattern was consistent with environmental influences, but it did not identify a particular trigger.
A separate study published on 2 November 2026 found that the incidence among Finnish children under 15 rose during the Covid-19 lockdown period, then declined towards pre-pandemic levels afterwards. Its authors suggested that changes in environmental exposure may help explain the pattern, rather than a direct effect of coronavirus infection. They cautioned that the observational findings cannot establish cause and effect.
Treatment has changed even as the cause remains uncertain
While the underlying cause remains unknown, care for people with type 1 diabetes has become more flexible. Thorn said many children now receive partially automated insulin pumps around the time of diagnosis. Fast-acting insulin also allows more freedom over meals and daily routines, although access to pumps still varies between Finnish regions.
The challenge for researchers remains identifying which combination of genetic susceptibility and environmental exposure helps explain Finland’s unusually high incidence. Neither the international comparisons nor the latest Finnish studies have provided a definitive answer.





